HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Regulation of TCGF production in T cells. II. Early membrane events after anti-Thy-1 binding by the TCGF-producing T lymphoma EL-4 G-12.

Abstract
The T cell lymphoma line EL-4 G-12 produces large quantities of TCGF (IL 2) shortly after exposure to anti-Thy-1 and cross-linking reagents. Early surface events that initiate nonconstitutive synthesis and secretion have been examined by fluorescent microscopy, EM analysis, flow cytometry of anti-Thy-1, and measurements of membrane polarization. The data show that anti-Thy-1 binding leads to immediate and rapid endocytosis and shedding of the antibody molecules, but with no change in membrane potential. Cross-linking of the anti-Thy-1 results in stabilization and accumulation of the antibody on the surface, and rapid hyperpolarization. The data suggest that cross-linking of ligand antibody interactions at the surface is a regulatory event involved in initiation of the signal for TCGF synthesis and secretion.
AuthorsM A Norcross, R T Smith, S Shimizu
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 132 Issue 2 Pg. 833-8 (Feb 1984) ISSN: 0022-1767 [Print] United States
PMID6418811 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Anti-Idiotypic
  • Antilymphocyte Serum
  • Cross-Linking Reagents
  • Fluoresceins
  • Interleukin-2
  • Thiocyanates
  • Fluorescein-5-isothiocyanate
Topics
  • Animals
  • Antibodies, Anti-Idiotypic (physiology)
  • Antilymphocyte Serum (immunology)
  • Binding Sites, Antibody
  • Cell Line
  • Cell Membrane (physiology)
  • Cross-Linking Reagents (pharmacology)
  • Endocytosis
  • Fluorescein-5-isothiocyanate
  • Fluoresceins
  • Fluorescent Antibody Technique
  • Goats
  • Interleukin-2 (biosynthesis)
  • Lymphoma (immunology)
  • Membrane Potentials
  • Mice
  • Rabbits
  • T-Lymphocytes (immunology)
  • Thiocyanates

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: